
A Hungarian innovation may expedite the journey from the laboratory to the patient.
Gene therapies could potentially transform the treatment of many severe diseases, but their success is often obstructed. Pre-existing antibodies in the body, which may neutralize these therapies, often cost hundreds of thousands of euros. Addressing this impediment, Hungarian researchers have created a new diagnostic method called coreTIA. For the first time, it provides scientists with an open-source tool, paving the way towards a global diagnostic standard.